| Amanda Harris Mcclelland, MD | |
|
7559 263rd St, Glen Oaks, NY 11004-1100 | |
| (646) 754-5034 | |
| Not Available |
| Full Name | Amanda Harris Mcclelland |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 7559 263rd St, Glen Oaks, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073958674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 276646 (New York) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 276646 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Harris Mcclelland, MD 7559 263rd St, Glen Oaks, NY 11004-1100 Ph: (718) 470-5727 | Amanda Harris Mcclelland, MD 7559 263rd St, Glen Oaks, NY 11004-1100 Ph: (646) 754-5034 |
News Archive
By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease.
Children with epilepsy are at high risk for depression, anxiety, and behavioral functioning disorders. Mood and behavior are known to change or improve in children following epilepsy surgery, but research is inconsistent concerning the extent of the change.
Using "BPA-free" plastic products could be as harmful to human health - including a developing brain - as those products that contain the controversial chemical, suggest scientists in a new study led by the University of Missouri and published in the Proceedings of the National Academy of Sciences.
A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.
› Verified 4 days ago
Avreliya Shapiro, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-8005 | |
Jeffrey Goltz, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-5744 Fax: 917-480-3017 | |
Jason Yan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-5730 | |
Stephanie Ilene Solow, PSYD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-8011 Fax: 718-962-8537 | |
Dr. Delbert Gail Robinson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-8195 Fax: 718-343-1659 | |
Dr. Anastasia Krivko, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-3539 | |
Kunsang P Gyato, PHD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7559 263rd St, Glen Oaks, NY 11004 Phone: 718-470-3148 Fax: 718-470-4678 |